Monographie - Filgrastim - Stabilis 4.0

Poslední aktualizace :
19/11/2024

Různé

Filgrastim

injekce

Stabilita roztoků

Stabilita směsí

Faktory ovlivňující stabilitu

Kompatibilita

Způsoby aplikace

Odkazy

pdf

Obchodní název

Obchodní název

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Accofil	Belgie, NÏmecko, Velká Británie
Biocilin	Mexiko
Duperan	Chile
Filgen	Argentina
Foltran	Chile
Granulokine	Itálie, ÿecko
Hebervital	Kolumbie
Inmunef	Kolumbie
Leucosos	Kolumbie
Lioplim	Chile
Neupogen	äpanÏlsko, Belgie, Chorvatsko, Dánsko, Finsko, Francie, Jihoafrická republika, Nizozemsko, Polsko, Portugalsko, Rakousko, Slovinsko, Švédsko, Švýcarsko, Turecko, USA, Velká Británie
Neutromax	Argentina
Neutropine	Argentina
Nivestim	Belgie, Francie, NÏmecko, Nizozemsko, Norsko, Velká Británie
Ratiograstim	NÏmecko, Rakousko, Švédsko, Velká Británie
Tevagrastim	NÏmecko, Nizozemsko, Norsko, Švédsko, Švýcarsko, Velká Británie

Odkazy

injekce

Odkazy : Filgrastim

	typ	uveřejnění
99	noviny	Trissel LA, Martinez JF. Compatibility of aztreonam with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 1086-1090.
104	noviny	Hall PD, Yui D, Lyons S, Bosso JA. Compatibility of filgrastim with selected antimicrobial drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 185-189.
182	noviny	Trissel LA, Gilbert DL, Martinez JF. Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 56-60.
244	noviny	Trissel LA, Martinez JF. Compatibility of filgrastim with selected drugs during simulated Y-site administration. Am J Hosp Pharm 1994 ; 51: 1907-1913.
2269	noviny	Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H. Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551.
3128	Laboratoř	Mitomycine (Amétycine®) - Résumé Caractéristiques du Produit Prostrakan 2013
3249	noviny	Singh BM, Dedhiya MG, Dinunzio J, Chan P, Kupiec TC, Trissel LA, Laudano JB. Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2011 ; 68: 2163-2169.
3256	noviny	Burnett B, Radic I. Stability of Hospira filgrastim following changes to thermal and photic storage conditions. EJHP 2011 ; 17, 5: 49-56.
3474	Laboratoř	Fluorouracil - Summary of Product Characteristics Accord Healthcare Limited 2009
3618	Laboratoř	Filgrastim (Neupogen®) - Summary of Product Characteristics Amgen 2014
3828	plakát	Thabit A.K, Hamada Y, Nicolau D.P. Ceftozolane/tazobactam physical compatibility during simulated Y-site administration. ASHP Midyear 2015
3829	plakát	So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L. Compatibility of isavunazonium sulfate during simulated Y-site administration. ASHP Midyear 2015
4055	noviny	Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D. Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 , 75, 1:36-44
4380	Laboratoř	Posaconazole (Noxafil®) - Summary of Product Characteristics Merck Sharp & Dohme Limited 2019
4471	Laboratoř	Amétycine 10 mg poudre pour solution injectable - Résumé des caractéristiques du produit - Oct 10, 2019 Kyowa Kirin Pharma 2019
4521	noviny	Polo C, D’Huart E, Lesperlette G, Vigneron J, Meyer F, Demoré B. Compatibility of injectable posaconazole with drugs commonly used in a hematology care unit. Pharmaceutical Technology in Hospital Pharmacy 2020
4650	Laboratoř	Ceftobiprole (Zevtera 500 mg powder for concentrate for solution for infusion.) Summary of Product Characteristics, Advanz Pharma updated 4 aug 2021. Advanz Pharma 2021

Mentions Légales